NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jun 30 04:00PM ET
3.00
Dollar change
-0.01
Percentage change
-0.33
%
IndexRUT P/E- EPS (ttm)-0.43 Insider Own5.03% Shs Outstand75.11M Perf Week-0.99%
Market Cap224.40M Forward P/E- EPS next Y-0.41 Insider Trans6.77% Shs Float71.03M Perf Month5.63%
Enterprise Value-8.97M PEG- EPS next Q-0.20 Inst Own87.98% Short Float4.41% Perf Quarter-12.54%
Income-31.96M P/S1.39 EPS this Y-126.92% Inst Trans-1.55% Short Ratio4.43 Perf Half Y-18.70%
Sales161.63M P/B0.57 EPS next Y29.94% ROA-6.91% Short Interest3.13M Perf YTD-16.90%
Book/sh5.28 P/C0.91 EPS next 5Y-18.71% ROE-7.77% 52W High4.92 -39.02% Perf Year-28.57%
Cash/sh3.31 P/FCF- EPS past 3/5Y6.40% - ROIC-7.83% 52W Low2.36 27.12% Perf 3Y4.90%
Dividend Est.- EV/EBITDA- Sales past 3/5Y-7.35% 3.75% Gross Margin41.66% Volatility4.62% 4.73% Perf 5Y-69.10%
Dividend TTM- EV/Sales-0.06 EPS Y/Y TTM-237.44% Oper. Margin-21.97% ATR (14)0.14 Perf 10Y-48.54%
Dividend Ex-Date- Quick Ratio10.94 Sales Y/Y TTM-46.95% Profit Margin-19.77% RSI (14)55.07 Recom2.50
Dividend Gr. 3/5Y- - Current Ratio12.34 EPS Q/Q-341.65% SMA202.46% Beta0.45 Target Price4.50
Payout- Debt/Eq0.04 Sales Q/Q-44.71% SMA505.65% Rel Volume0.71 Prev Close3.01
Employees501 LT Debt/Eq0.03 EarningsMay 07 AMC SMA200-16.08% Avg Volume707.81K Price3.00
IPONov 17, 1986 Option/ShortYes / Yes EPS/Sales Surpr.-29.55% 2.57% Trades Volume502,243 Change-0.33%
Date Action Analyst Rating Change Price Target Change
Jan-03-23Resumed Evercore ISI In-line $5
Sep-22-21Downgrade Raymond James Outperform → Mkt Perform
Aug-21-20Initiated Evercore ISI Outperform $22
Aug-10-20Initiated JP Morgan Neutral $18
Aug-10-20Initiated Citigroup Buy $18
Aug-07-20Upgrade Raymond James Mkt Perform → Outperform $16
Jun-25-20Initiated Lake Street Buy $19
Apr-21-20Resumed Stephens Equal-Weight $14
Oct-23-18Resumed Raymond James Mkt Perform
Jul-16-18Downgrade Stephens Overweight → Equal-Weight
May-20-25 11:35AM
May-14-25 08:00AM
May-08-25 09:50AM
03:33AM
May-07-25 08:02PM
08:01PM Loading…
08:01PM
05:55PM
04:47PM
04:05PM
May-01-25 05:45PM
Apr-30-25 03:47PM
Apr-23-25 04:05PM
07:40AM
Apr-10-25 11:35AM
Apr-02-25 03:35PM
07:30AM Loading…
Mar-24-25 07:30AM
Feb-26-25 09:03AM
02:16AM
Feb-25-25 06:10PM
05:15PM
04:05PM
01:50AM
Feb-14-25 08:45AM
Jan-27-25 12:00PM
Jan-23-25 09:40AM
Jan-07-25 04:05PM
09:40AM
08:50AM
07:05AM
Dec-19-24 04:02PM
07:05AM Loading…
Dec-02-24 07:05AM
Nov-28-24 09:40AM
Nov-18-24 04:05PM
Nov-12-24 09:40AM
Nov-07-24 10:00AM
Nov-06-24 05:55PM
04:58PM
04:05PM
Nov-05-24 08:01AM
Oct-22-24 04:05PM
Oct-13-24 02:11PM
Oct-04-24 05:03PM
Sep-12-24 01:25AM
Sep-09-24 07:05AM
Aug-07-24 10:16AM
Aug-06-24 06:25PM
05:20PM
04:05PM
Jul-22-24 04:05PM
Jun-27-24 07:05AM
Jun-07-24 06:09PM
May-13-24 10:47AM
May-10-24 03:04PM
May-09-24 01:54PM
08:29AM
03:48AM
May-08-24 08:57PM
06:20PM
05:17PM
04:05PM
Apr-22-24 08:00AM
Apr-18-24 11:30AM
Mar-21-24 08:31AM
Feb-28-24 09:23AM
08:55AM
Feb-27-24 05:11PM
04:48PM
04:05PM
Feb-13-24 04:05PM
Feb-01-24 06:42PM
Jan-04-24 07:05AM
Dec-22-23 05:01AM
Nov-27-23 09:55AM
Nov-13-23 04:15PM
Nov-09-23 11:12AM
Nov-08-23 12:14PM
08:40AM
Nov-07-23 06:50PM
05:47PM
04:59PM
04:05PM
Oct-23-23 04:05PM
Aug-09-23 06:02AM
Aug-05-23 08:52AM
Aug-04-23 11:45AM
Aug-03-23 05:55PM
04:58PM
04:05PM
Jul-20-23 04:05PM
07:05AM
Jun-29-23 07:07AM
Jun-21-23 08:00PM
Jun-13-23 04:05PM
Jun-08-23 11:03AM
Jun-01-23 06:29AM
May-16-23 06:08AM
May-12-23 07:12AM
May-11-23 11:03AM
May-10-23 05:35PM
04:34PM
OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic tests and molecular collection devices designed to detect or diagnose critical medical conditions. It operates through the OSUR and DNAG segments. The OSUR segment offers oral fluid diagnostic products and specimen collection devices. The DNAG segment produces specimen collection kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, pharmacogenomics, personalized medicine, microbiome, and animal genetics markets. The company was founded by Michael J. Gausling in 2000 in and is headquartered in Bethlehem, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gagliano Nancy JDirectorFeb 27 '25Buy3.0812,75039,27091,524Mar 03 09:08 AM
EGLINTON MANNER CARRIEPresident & CEOFeb 28 '25Buy3.4928,670100,0271,288,334Mar 03 09:07 AM
EGLINTON MANNER CARRIEPresident & CEOFeb 27 '25Buy3.1578,625247,3781,259,664Feb 27 09:14 PM
Kenny John P.DirectorFeb 27 '25Buy3.1747,659151,21770,915Feb 27 09:14 PM
McGrath Kenneth JChief Financial OfficerFeb 27 '25Buy3.1564,000201,683371,013Feb 27 09:14 PM
Marmora LelioDirectorFeb 27 '25Buy3.067,00021,42067,720Feb 27 04:19 PM